Omron Healthcare CEO Ranndy Kellogg on the company’s collaborative approach to innovation

Omron Healthcare is one of the leading companies within the blood pressure monitoring space, but hasn’t been content to rest on its laurels. The company has continued...

TytoCare joins Epic App Orchard to expand reach of its telehealth service

Digital health startup TytoCare has joined the Epic App Orchard, a marketplace where providers can browse apps made by third-party software developers, according to a news release. Through...

FDA approves Novartis gene therapy Zolgensma for spinal muscular atrophy

The Food and Drug Administration has given another approval to a gene therapy, this time for a rare disease that causes paralysis. Swiss drugmaker Novartis announced the...

Why precision medicines for oncology demands precision engagement

Life sciences companies overwhelmed with large volumes of information and data available – both in terms of therapies and patient-reported outcomes – must establish a...

How a focus on food can move the needle to cost avoidance in healthcare

L to R: moderator Dr. Thomas Hawes, managing director for Sandbox Industries; Rick Born, CEO of Aetna Better Health of Louisiana; Dr. Julia Jenkins, medical director...

Report: Amazon developing emotion-sensing wearable device

Amazon has a health-oriented wearable in the works that has the potential to use voice recognition technology to sense emotional states, according to a report from...

FDA is looking for new companies to test out its pre-cert pilot program

The Food and Drug Administration has put out a call for volunteer companies to test out the its digital health pre-certification program for software as a...

Scott Gottlieb returns to NEA – this time with some valuable regulatory experience under...

One of the largest venture capital firms in the world is adding an enviable member to its healthcare investment team: the man who just stepped down...

MIT researcher, alleged to have copied antibody research Otsuka acquired, evaluating potential legal action

Last year, Japanese drugmaker Otsuka Pharmaceutical paid $430 million to acquire Waltham, Massachusetts-based Visterra, a firm that combines computational and experimental technologies to develop monoclonal antibodies...

Midwestern hospital network launches $100M venture fund

At the inaugural MedCity INVEST Pop Health conference in New Orleans on May 22, West Des Moines, Iowa-based UnityPoint Health announced that it has launched a...

Must Read